article thumbnail

Feasibility of the Diabetes Self-Management Coaching Program for Individuals with Type 2 Diabetes in Primary Care. [Diabetes and endocrine disease]

Annals of Family Medicine

Context: The rampant rise in the prevalence of diabetes presents a public health burden and a challenge to the primary care setting. Diabetes Self-management Coaching is an emergent, client-centered, solution-focused approach to enhancing self-efficacy and self-care behavior.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. The study was terminated early because benefits were already significantly visible by October 2023. semaglutide 1.0 mg or placebo in 2019. mg is not recommended. mg is not recommended.

Diabetes 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug linked to lower risk of dementia in people with diabetes

Medical Xpress

People with diabetes are twice as likely to develop dementia as those without the disease. In a new study, people with newly diagnosed type 2 diabetes who took the diabetes drug pioglitazone were less likely to later develop dementia than those who did not take the drug.

article thumbnail

One-hour endoscopic procedure could eliminate need for insulin for type 2 diabetes

Medical Xpress

A procedure that uses controlled electrical pulses to induce changes to the lining of the first part of the small intestine could allow patients with type 2 diabetes to stop taking insulin and still maintain glycemic control, according to a preliminary first-in-human study that will be presented at Digestive Disease Week (DDW) 2023.

article thumbnail

Spinal cord stimulation may help diabetic neuropathy

Medical Xpress

People with painful diabetic neuropathy may be able to get relief from high-frequency spinal cord stimulation, according to a preliminary study released today, February 28, 2023, that will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

article thumbnail

More Indonesian children are living with diabetes—so what can we do to prevent it?

Medical Xpress

Indonesian children under 18 were 70 times more likely to be living with diabetes in January 2023 than they were in 2010, the Indonesian Pediatric Society revealed this month.

article thumbnail

Health and Mood Benefits of Semaglutide in HF

Physician's Weekly

Researchers examined the effects of semaglutide on body weight, health status, and mood over 1 year in individuals with HF and obesity. They assessed 122 individuals with HF and obesity who were treated consecutively with semaglutide between January 2019 and August 2023.